SUBSCRIBE
SUBSCRIBE
News   Deals

Solvay SA Says Mulling Options For Drugs Unit

April 1, 2009 | 
1 min read
AMSTERDAM, April 1 (Reuters) - Belgian drugs, chemicals and plastics maker Solvay (SOLB.BR) said on Wednesday it is analysing various options for its pharmaceutical activities and may enter talks with various third parties about the business.
Mergers & acquisitions Europe
MORE ON THIS TOPIC
Illustration of businessman running back around
Autoimmune disease
Sanofi Taps Dren Again in up to $1.7B Autoimmune Partnership
December 15, 2025
 · 
1 min read
 · 
Annalee Armstrong
Rheumatoid arthritis (RA) commonly causes inflammation in the hands, leading to pain, swelling, and stiffness in the joints, particularly the small joints of the fingers and wrists. This inflammation results from the immune system attacking the body's own joint tissues, causing the synovium (lining of the joint) to become inflamed and release chemicals that damage nearby tissues.
Mergers & acquisitions
Sobi Makes $1.5B Gout Play With Arthrosi Acquisition
December 15, 2025
 · 
2 min read
 · 
Tristan Manalac
Hand with the ace of Spades playing card. Vintage color engraving stylized drawing. Vector illustration
Mergers & acquisitions
Pfizer Is Not a Done Dealmaker After Metsera Buy, With $6B More To Spend
December 10, 2025
 · 
1 min read
 · 
Annalee Armstrong
Hands holding red circle. Sensing energy between palms. Concept of human relation, togetherness, partnership, connection, contact or network. Design for banner, flyer, poster, cover or brochure.
Japan
Japanese Pharmas Looking Beyond Borders for M&A to US, EU
December 10, 2025
 · 
7 min read
 · 
Dan Samorodnitsky